Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial.
de Vries HM, Rafael TS, Gil-Jimenez A, de Feijter JM, Bekers E, van der Laan E, Lopez-Yurda M, Hooijberg E, Broeks A, Peters D, Seignette IM, Pos FJ, Horenblas S, van Rhijn BWG, Jordanova ES, Brouwer OR, Schaake E, van der Heijden MS. de Vries HM, et al. Among authors: bekers e. J Clin Oncol. 2023 Nov 1;41(31):4872-4880. doi: 10.1200/JCO.22.02894. Epub 2023 Jul 24. J Clin Oncol. 2023. PMID: 37487169 Clinical Trial.
The Diagnostic Value of FDG-PET/CT for Urachal Cancer.
Stokkel LE, Stokkel MPM, Donswijk ML, Lahaye MJ, Bekers EM, van Rhijn BWG, Mertens LS. Stokkel LE, et al. Among authors: bekers em. Clin Genitourin Cancer. 2021 Oct;19(5):373-380. doi: 10.1016/j.clgc.2021.03.002. Epub 2021 Mar 17. Clin Genitourin Cancer. 2021. PMID: 33858788
Distinct Patterns of Myeloid Cell Infiltration in Patients With hrHPV-Positive and hrHPV-Negative Penile Squamous Cell Carcinoma: The Importance of Assessing Myeloid Cell Densities Within the Spatial Context of the Tumor.
Rafael TS, de Vries HM, Ottenhof SR, Hofland I, Broeks A, de Jong J, Bekers E, Horenblas S, de Menezes RX, Jordanova ES, Brouwer OR. Rafael TS, et al. Among authors: bekers e. Front Immunol. 2021 Jun 14;12:682030. doi: 10.3389/fimmu.2021.682030. eCollection 2021. Front Immunol. 2021. PMID: 34194435 Free PMC article.
First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial.
Stibbe JA, de Barros HA, Linders DGJ, Bhairosingh SS, Bekers EM, van Leeuwen PJ, Low PS, Kularatne SA, Vahrmeijer AL, Burggraaf J, van der Poel HG. Stibbe JA, et al. Lancet Oncol. 2023 May;24(5):457-467. doi: 10.1016/S1470-2045(23)00102-X. Epub 2023 Apr 14. Lancet Oncol. 2023. PMID: 37062295 Clinical Trial.
A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients.
Wit EMK, KleinJan GH, Berrens AC, van Vliet R, van Leeuwen PJ, Buckle T, Donswijk ML, Bekers EM, van Leeuwen FWB, van der Poel HG. Wit EMK, et al. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2861-2871. doi: 10.1007/s00259-023-06191-7. Epub 2023 Apr 10. Eur J Nucl Med Mol Imaging. 2023. PMID: 37036490 Clinical Trial.
60 results